News / Health

Cancer Drug Unmasks HIV in Immune Cells

A member of the audience looks at slides during a speech given by leading AIDS vaccine official in Washington, July 25, 2012.
A member of the audience looks at slides during a speech given by leading AIDS vaccine official in Washington, July 25, 2012.
Jessica Berman
WASHINGTON — People infected with HIV, the virus that causes AIDS, must take anti-retroviral drugs for the rest of their lives in order to control their disease. 

Otherwise, reservoirs of dormant virus hiding within the immune system can become active, and the infection can reemerge. Now, researchers have discovered that a cancer drug can dislodge these latent copies of the AIDS virus. They view the development as a critical step toward curing HIV-infected people.

HIV has evolved a way to survive inside the human body by integrating itself into the genetic architecture of immune-system T-cells, the specialized white blood cells targeted by the AIDS virus. Anti-retroviral drugs can suppress HIV to near undetectable levels, giving the immune system a chance to repair itself. But the AIDS virus is always lurking in miniscule numbers - roughly one in every million T cells - and threatening to come back to life should an individual ever stop taking the anti-retroviral cocktail.  

Now, researchers have succeeded in flushing this latent virus out of its hiding place, with a drug used to treat lymphoma, a rare and potentially deadly cancer of the lymphatic system.  

David Margolis, a professor of microbiology and immunology at the University of North Carolina Chapel Hill has been studying how HIV hides, dormant, within immune-system cells, says that in some lymphomas, the drug, vorinostat, makes cancer cells die. But Margolis adds that in HIV-infected cells, the cancer drug causes the latent virus to show itself.

“Theoretically, doing this clinically would be a way to sort of unmask the hidden virus; flush the virus out of hiding," he says. "And that might then allow us to develop ways to get rid of the leftover virus in people that are on treatment so they could stop treatment and there would be nowhere for the virus to come back from.”

Margolis and his colleagues studied eight HIV-infected patients who were medically stable on anti-retroviral therapy. Their levels of HIV CD4 T cells, which the virus uses to reproduce itself, were measured both before and after the men were given vorinostat.

“What we saw in every single person was a tiny amount of virus detectable before the dose of the drug," he says. "And the amount of virus that was detectable went up on average about five-fold, five times, after a single exposure to the drug.”

Margolis says his so-called “proof of concept” experiment demonstrates that HIV can be flushed out of hiding with vorinostat and then targeted for destruction by anti-AIDS drugs.

But none of the participants was cured, he adds.

Margolis was joined in the work by researchers at the U.S. National Cancer Institute, Harvard University School of Public Health in Massachusetts, the University of California San Diego and Merck and Company, the maker of vorinostat.

Their article on the use of the cancer drug vorinostat in the treatment of HIV was published in the journal Nature.

You May Like

At International AIDS Conference One Goal, Many Paths

The 12,000 delegates attending 20th International AIDS Conference in Melbourne have vastly different visions about how to eradicate disease More

Disasters May Doom Malaysia’s Flag Carrier

Even before loss of two jets loaded with passengers on international flights, company had been operating in red for three years, accumulating deficit of $1.3 billion More

Afghan Presidential Vote Audit Continues Despite Glitches

Process has been marred by walkouts by representatives of two competing candidates, Abdullah Abdullah and Ashraf Ghani More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Nature of Space Exploration Enters New Agei
X
Elizabeth Lee
July 20, 2014 2:36 AM
Forty-five years ago this month, the first humans walked on the moon. It was during an era of the space race between the United States and the Soviet Union. World politics have changed since then and -- as Elizabeth Lee reports -- so has the nature of space exploration.
Video

Video Nature of Space Exploration Enters New Age

Forty-five years ago this month, the first humans walked on the moon. It was during an era of the space race between the United States and the Soviet Union. World politics have changed since then and -- as Elizabeth Lee reports -- so has the nature of space exploration.
Video

Video Chicago’s Argonne Lab Developing Battery of the Future

In 2012, the U.S. Department of Energy’s Office of Science awarded a $120 million grant to a new technology center focused on battery development - headquartered at Argonne National Laboratory in suburban Chicago, Illinois. As VOA’s Kane Farabaugh reports, there scientists are making the next technological breakthroughs in energy storage.
Video

Video In NW Pakistan, Army Offensive Causes Massive Number of Displaced

Pakistan’s army offensive in North Waziristan has resulted in the large-scale displacement of the local population. VOA's Ayaz Gul reports from northwest Pakistan where authorities say around 80 percent of the estimated 1 million internally displaced persons [IDPs] have settled in Bannu district, while much of the remaining 20 percent are scattered in nearby cities.
Video

Video Kurdish Peshmerga Force Secures Kirkuk, Its Oil

The Kurdistan regional government has sent its Peshmerga troops into the adjacent province of Kirkuk to drive out insurgents, and to secure the area's rich oil fields. By doing this, the regional government has added a fourth province to the three it officially controls. The oil also provides revenue that could make an independent Kurdistan economically strong. VOA’s Jeffrey Young went out with the Peshmerga and filed this report.
Video

Video Malaysia Reeling: Second Air Disaster in Four Months

Malaysia is reeling from the second air disaster in four months involving the country’s flag carrier. Flight 340 vanished in March and despite an extensive search, no debris has been found. And on Thursday, Flight 17, likely hit by a surface-to-air missile, came apart over eastern Ukraine. The two incidents together have left more than 500 people dead. VOA Correspondent Steve Herman reports from Kuala Lumpur.
Video

Video Diplomatic Crisis Grows Over MH17 Plane Crash

The Malaysia Airlines crash in eastern Ukraine is drawing reaction from leaders around the world. With suspicions growing that a surface-to-air missile shot down the aircraft, there are increasing tensions in the international community over who is to blame. Henry Ridgwell reports for VOA from London.
Video

Video Undocumented Immigrants Face Perilous Journey to US, No Guarantees

Every day, hundreds of undocumented immigrants from Central America attempt the arduous journey through Mexico and turn themselves over to U.S. border patrol -- with the hope that they will not be turned away. But the dangers they face along the way are many, and as Ramon Taylor reports from the Rio Grande Valley in Texas, their fate rests on more than just the reception they get at the US border.
Video

Video Scientists Create Blackest Material Ever

Of all the black things in the universe only the infamous "black holes" are so black that not even a tiny amount of light can bounce back. But scientists have managed to create material almost as black, and it has enormous potential use. VOA’s George Putic has more.
Video

Video Fog Collector Transforming Maasai Water Harvesting in Kenya

The Maasai people of Kenya are known for their cattle-herding, nomadic lifestyle. But it's an existence that depends on access to adequate water for their herds and flocks. Lenny Ruvaga reports for VOA, on a "fog collector."

AppleAndroid